NPPA issued a notification regarding the fixation of the retail price of Atorvastatin Calcium IP Eq. to Atorvastatin 10 mg + Fenofibrate IP 160 mg for M/s BRD Medilabs (Unit II) (Manufacturer) and for M/s Troikaa Pharmaceuticals Ltd. (Marketer)

Feb 24, 2025 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on February 21, 2025, issued a notification regarding the fixation of the retail price of Atorvastatin Calcium IP Eq. to Atorvastatin 10 mg + Fenofibrate IP 160 mg for M/s BRD Medilabs (Unit II) (Manufacturer) and for M/s Troikaa Pharmaceuticals Ltd. (Marketer).

The following has been stated: -

•For each Film Coated Tablet Contains: Atorvastatin Calcium IP Eq. to Atorvastatin 10 mg + Fenofibrate IP 160 mg for M/s BRD Medilabs (Unit II) (Manufacturer) and for M/s Troikaa Pharmaceuticals Ltd. (Marketer) the retail price is 16.17 (Rs)

[Notification No. 19(4458)/2025/DP/NPPA/Div.III/10000/2025]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT